Drug intelligence / Profile preview

troxerutin + cerebroprotein

Development stage
Phase 4
Lead developer
Harbin Yuheng Pharmaceutical
Modality
Small Molecules, Peptides
Administration
Intravenous
01

Overview

Troxerutin + cerebroprotein is a combination therapeutic injection primarily utilized in China for the treatment of cerebrovascular disorders and traumatic brain injuries. The product combines troxerutin, a flavonoid derivative with vasoprotective and antioxidant properties, with cerebroprotein hydrolysate, a mixture of peptides and amino acids derived from animal brain tissue. Troxerutin functions by reducing capillary permeability, inhibiting platelet aggregation, and improving microcirculation. Cerebroprotein hydrolysate provides neurotrophic support, promoting neuronal survival, metabolism, and repair by mimicking the effects of endogenous neurotrophic factors. This synergistic combination is indicated for conditions such as ischemic stroke, sequelae of cerebral hemorrhage, and cognitive dysfunction following brain trauma.

Brand names
Qu Ke Lu Ding Nao Dan Bai Shui Jie Wu Zhu She Ye
Other names
Troxerutin and Cerebroprotein Hydrolysate InjectionTroxerutin and Cerebroprotein Injection
02

Targets

HYAL (Hyaluronidase family (HYAL))NTRK1 (Tropomyosin-related receptor kinase A)NTRK2 (Tropomyosin-related kinase receptor type B)NGFR (p75NTR)

Beyond the preview

Go deeper on troxerutin + cerebroprotein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on troxerutin + cerebroprotein.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call